VELAN CAPITAL INVESTMENT MANAGEMENT LP

PrivateCIK: 1848809
Location

ALPHARETTA, GA

๐Ÿ“‹ What this filing means

VELAN CAPITAL INVESTMENT MANAGEMENT LP filed this quarterly 13Fโ€‘HR report disclosing 50 equity positions with a total reported market value of $101.24M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

50
Positions
$101.24M
Total AUM (reported)
24.31M
Total Shares

Allocation by class

TOTAL AUM$101.24M50 positions
COM$47.73M47.2%
COMNEW$36.51M36.1%
SPONSOREDADS$8.99M8.9%
COMSTK$6.48M6.4%
CALL$1.29M1.3%
SHS$97.5K0.1%
SHSEURO$91.8K0.1%

Portfolio Concentration

Top 331.0%4โ€“1038.3%11โ€“2527.7%Rest3.0%TOP 1069.3%0%100%
Top 3$31.41M31.0%
4โ€“10$38.77M38.3%
11โ€“25$28.06M27.7%
Rest$3.00M3.0%

Top 3 weight

31.0%

Top 10 weight

69.3%

Voting Authority Distribution

Total shares with voting rights: 24.31M

Sole

Full voting authority

23.49M

shares

% of voting shares96.6%
Shared

Joint voting authority

814.41K

shares

% of voting shares3.4%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole48
Shared0
Other2
Dominant voting typeSole ยท 96.6% of voting shares
Institutional Holdings50
Rows:

HERONTHERAPEUTICSINC

SOLE
COM
Shares6.99M
TypeSH
Market value$14.46M
14.29%
Sole
6.99M
Shared
0.00
None
0.00

VERONAPHARMAPLC

SOLE
SPONSOREDADS
Shares95K
TypeSH
Market value$8.99M
8.88%
Sole
95K
Shared
0.00
None
0.00

JASPERTHERAPEUTICSINC

SOLE
COMNEW
Shares1.43M
TypeSH
Market value$7.96M
7.86%
Sole
1.19M
Shared
245.33K
None
0.00

PROTARATHERAPEUTICSINC

SOLE
COMSTK
Shares2.14M
TypeSH
Market value$6.48M
6.40%
Sole
2.14M
Shared
0.00
None
0.00

ZEVRATHERAPEUTICSINC

SOLE
COMNEW
Shares715K
TypeSH
Market value$6.30M
6.22%
Sole
715K
Shared
0.00
None
0.00

TOURMALINEBIOINC

OTR
COM
Shares393.89K
TypeSH
Market value$6.30M
6.22%
Sole
74.81K
Shared
319.08K
None
0.00

PRAXISPRECISIONMEDICINESI

SOLE
COMNEW
Shares149.33K
TypeSH
Market value$6.28M
6.20%
Sole
149.33K
Shared
0.00
None
0.00

CIDARATHERAPEUTICSINC

SOLE
COMNEW
Shares100K
TypeSH
Market value$4.87M
4.81%
Sole
100K
Shared
0.00
None
0.00

ALUMISINC

SOLE
COM
Shares1.62M
TypeSH
Market value$4.86M
4.80%
Sole
1.62M
Shared
0.00
None
0.00

ARVINASINC

SOLE
COM
Shares500K
TypeSH
Market value$3.68M
3.64%
Sole
500K
Shared
0.00
None
0.00

SCPHARMACEUTICALSINC

SOLE
COM
Shares917.67K
TypeSH
Market value$3.50M
3.45%
Sole
917.67K
Shared
0.00
None
0.00

REZOLUTEINC

SOLE
COMNEW
Shares750K
TypeSH
Market value$3.35M
3.30%
Sole
750K
Shared
0.00
None
0.00

LIQUIDIACORPORATION

SOLE
COMNEW
Shares239.26K
TypeSH
Market value$2.98M
2.94%
Sole
239.26K
Shared
0.00
None
0.00

MINERALYSTHERAPEUTICSINC

SOLE
COM
Shares174.60K
TypeSH
Market value$2.36M
2.33%
Sole
174.60K
Shared
0.00
None
0.00

SUTROBIOPHARMAINC

SOLE
COM
Shares3.06M
TypeSH
Market value$2.18M
2.16%
Sole
3.06M
Shared
0.00
None
0.00

INSPIREMDINC

SOLE
COM
Shares904.03K
TypeSH
Market value$2.05M
2.03%
Sole
904.03K
Shared
0.00
None
0.00

PERSPECTIVETHERAPEUTICSINC

SOLE
COMNEW
Shares500K
TypeSH
Market value$1.72M
1.70%
Sole
500K
Shared
0.00
None
0.00

REPLIMUNEGROUPINC

SOLE
COM
Shares183.08K
TypeSH
Market value$1.70M
1.68%
Sole
183.08K
Shared
0.00
None
0.00

TELABIOINC

SOLE
COM
Shares747.41K
TypeSH
Market value$1.45M
1.43%
Sole
747.41K
Shared
0.00
None
0.00

EDESABIOTECHINC

OTR
COMNEW
Shares687.50K
TypeSH
Market value$1.40M
1.38%
Sole
437.50K
Shared
250K
None
0.00

NEKTARTHERAPEUTICS

SOLE
CALL
Shares50K
TypeSH
Market value$1.29M
1.28%
Sole
50K
Shared
0.00
None
0.00

VIRIDIANTHERAPEUTICSINC

SOLE
COM
Shares86.50K
TypeSH
Market value$1.21M
1.19%
Sole
86.50K
Shared
0.00
None
0.00

UPSTREAMBIOINC

SOLE
COM
Shares107K
TypeSH
Market value$1.17M
1.16%
Sole
107K
Shared
0.00
None
0.00

ELEDONPHARMACEUTICALSINC

SOLE
COM
Shares338.97K
TypeSH
Market value$918.6K
0.91%
Sole
338.97K
Shared
0.00
None
0.00

AVALOTHERAPEUTICSINC

SOLE
COMNEW
Shares154.97K
TypeSH
Market value$773.3K
0.76%
Sole
154.97K
Shared
0.00
None
0.00
Page 1 of 2
VELAN CAPITAL INVESTMENT MANAGEMENT LP 13F Holdings โ€” 50 Positions | Finecho